MCT4介导的乳酸外排促进STING依赖性树突状细胞抗肿瘤免疫反应
MCT4-mediated lactate efflux promotes STING-dependent dendritic cell antitumor immunity
Rui Ding, Yaqing Yuan, Tongchang Xu, Jingwen Zhang, Yi Zhu, Bing Yao, Shuang Qu, Zhilin Hu
Journal:Cell Reports
IF:7.7
DOI:10.1016/j.celrep.2026.117778
PMID:42541722
Published:2026-08-01
research field:药物发现病毒学分子医学肝病学
Abstract
The mechanisms by which DCs evolutionarily adapt to lactate accumulation to maintain their functions remain largely elusive. Here, our study highlights the MCT4-lactate axis as an intrinsic metabolic checkpoint governing intratumoral DC activity. Intratumoral lactate supplementation impedes DC-dependent antitumor activity. Additionally, we observe that MCT4 is highly expressed in intratumoral DCs and mediates lactate efflux to boost DC function. Pharmacological or genetic inhibition of MCT4 suppresses DC antitumor responses. Mechanistically, MCT4-controlled lactate efflux sustains STING signaling and STING-dependent antitumor immunity. Loss of MCT4 in DCs augments lactate accumulation, subsequently reducing intracellular pH and disrupting the interaction between G3BP1 and cGAS, ultimately leading to impaired dsDNA sensing by cGAS. Importantly, the MCT4-lactate axis supports STING-dependent DC activity in ccRCC patient samples. Our findings uncover how intratumoral DCs adapt to lactate and suggest that targeting the MCT4-lactate axis represents a promising cancer immunotherapy strategy.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


